Mumbai: Alembic Pharmaceuticals today announced that it has successfully completed the United States Food and Drug Administration (USFDA) inspection for its API-III Facility located at Karakhadi.
The inspection was successfully completed without any Form 483 observation. It was conducted from 17th March 2025 to 21st March 2025.
